- Home
- ORIC vs CXM Comparison
ORIC vs CXM Comparison
Compare ORIC & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | CXM |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | United States |
| Employees | 111 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ORIC | CXM |
|---|---|---|
| Price | $13.74 | $7.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $19.73 | $8.28 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 05-05-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $857,200,000.00 |
| Revenue This Year | N/A | $2.52 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | ★ N/A | $371.50 |
| Revenue Growth | N/A | ★ 7.64 |
| 52 Week Low | $7.23 | $4.72 |
| 52 Week High | $14.93 | $8.85 |
Technical Indicators
Market Signals| Indicator | ORIC | CXM |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 70.36 |
| Support Level | $13.12 | $7.17 |
| Resistance Level | $13.97 | $8.21 |
| Average True Range (ATR) | 0.63 | 0.22 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 52.96 | 84.00 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.